glucoraphanin and Cardiovascular-Diseases

glucoraphanin has been researched along with Cardiovascular-Diseases* in 3 studies

Reviews

1 review(s) available for glucoraphanin and Cardiovascular-Diseases

ArticleYear
Sulforophane glucosinolate. Monograph.
    Alternative medicine review : a journal of clinical therapeutic, 2010, Volume: 15, Issue:4

    Topics: Animals; Aniridia; Anticarcinogenic Agents; Antioxidants; Brassica; Cardiovascular Diseases; Cerebellar Ataxia; Clinical Trials as Topic; Glucosinolates; Humans; Imidoesters; Intellectual Disability; Neoplasms; Oxidative Stress; Oximes; Sulfoxides

2010

Trials

1 trial(s) available for glucoraphanin and Cardiovascular-Diseases

ArticleYear
A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial function.
    The American journal of clinical nutrition, 2013, Volume: 98, Issue:3

    Observational and experimental studies suggest that diets rich in cruciferous vegetables and glucosinolates may reduce the risk of cancer and cardiovascular disease (CVD).. We tested the hypothesis that a 12-wk dietary intervention with high-glucoraphanin (HG) broccoli would modify biomarkers of CVD risk and plasma metabolite profiles to a greater extent than interventions with standard broccoli or peas.. Subjects were randomly assigned to consume 400 g standard broccoli, 400 g HG broccoli, or 400 g peas each week for 12 wk, with no other dietary restrictions. Biomarkers of CVD risk and 347 plasma metabolites were quantified before and after the intervention.. No significant differences in the effects of the diets on biomarkers of CVD risk were found. Multivariate analyses of plasma metabolites identified 2 discrete phenotypic responses to diet in individuals within the HG broccoli arm, differentiated by single nucleotide polymorphisms associated with the PAPOLG gene. Univariate analysis showed effects of sex (P < 0.001), PAPOLG genotype (P < 0.001), and PAPOLG genotype × diet (P < 0.001) on the plasma metabolic profile. In the HG broccoli arm, the consequence of the intervention was to reduce variation in lipid and amino acid metabolites, tricarboxylic acid (TCA) cycle intermediates, and acylcarnitines between the 2 PAPOLG genotypes.. The metabolic changes observed with the HG broccoli diet are consistent with a rebalancing of anaplerotic and cataplerotic reactions and enhanced integration of fatty acid β-oxidation with TCA cycle activity. These modifications may contribute to the reduction in cancer risk associated with diets that are rich in cruciferous vegetables. This trial was registered at clinicaltrials.gov as NCT01114399.

    Topics: Aged; Amino Acids; Biomarkers; Brassica; Cardiovascular Diseases; Diet; Female; Genotype; Glucosinolates; Humans; Imidoesters; Lipids; Male; Metabolome; Middle Aged; Mitochondria; Multivariate Analysis; Nucleotidyltransferases; Oximes; Plant Extracts; Polymorphism, Single Nucleotide; Sex Factors; Sulfoxides

2013

Other Studies

1 other study(ies) available for glucoraphanin and Cardiovascular-Diseases

ArticleYear
Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, May-04, Volume: 101, Issue:18

    Imbalance between production and scavenging of superoxide anion results in hypertension by the inactivation of nitric oxide, and the increased oxidative stress from the resultant peroxynitrite that is produced promotes inflammatory processes such as atherosclerosis. Induction of phase 2 proteins promotes oxidant scavenging. We hypothesized that intake of dietary phase 2 protein inducers would ameliorate both hypertension and atherosclerotic changes in the spontaneously hypertensive stroke-prone rat. For 5 days/week for 14 weeks, we fed rats 200 mg/day of dried broccoli sprouts that contained glucoraphanin, which is metabolized into the phase 2 protein-inducer sulforaphane (Group A), sprouts in which most of the glucoraphanin was destroyed (Group B), or no sprouts (Group C). After 14 weeks of treatment, no significant differences were seen between rats in Groups B and C. Rats in Group A had significantly decreased oxidative stress in cardiovascular and kidney tissues, as shown by increased glutathione (GSH) content and decreased oxidized GSH, decreased protein nitrosylation, as well as increased GSH reductase and GSH peroxidase activities. Decreased oxidative stress correlated with better endothelial-dependent relaxation of the aorta and significantly lower (20 mm Hg) blood pressure. Tissues from Groups B and C had considerable numbers of infiltrating activated macrophages, indicative of inflammation, whereas animals in Group A had few detectable infiltrating macrophages. There is interest in dietary phase 2 protein inducers as means of reducing cancer incidence. We conclude that a diet containing phase 2 protein inducers also reduces the risk of developing cardiovascular problems of hypertension and atherosclerosis.

    Topics: Animals; Brassica; Cardiovascular Diseases; Glucose; Glucosinolates; Glutathione; Hypertension; Imidoesters; Inflammation; Macrophages; Male; NF-kappa B; Oxidative Stress; Oximes; Rats; Sulfoxides

2004